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Wilms' Tumor 1 and Dax-1 Modulate
the Orphan Nuclear Receptor SF-1
in Sex-Specific Gene Expression
altered structural characteristics of the ventromedial hy-
pothalamus (Ikeda et al., 1995). These data demonstrate
the essential role of SF-1 in the development of the
hypothalamic-pituitary-gonadal axis. The sexually dimor-
phic expression pattern exhibited by SF-1 (Hatano et
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al., 1994; Shen et al., 1994) and the role of SF-1 in regu-University of California at San Francisco
lating MIS and testosterone synthesis provide strongSan Francisco, California 94143-0444
evidence that this orphan nuclear receptor mediates
male-specific gene expression. Indeed, transgenic stud-
ies using the proximal MIS promoter established thatSummary
the SF-1±binding site (MIS-RE-1) is required for the sex-
dependent onset and maintenance of MIS expression
Products of steroidogenic factor 1 (SF-1) and Wilms'
in gonadal development. Mutations within the core SF-tumor 1 (WT1) genes are essential for mammalian go-
1±binding site abolish MIS promoter activity in vivo andnadogenesis prior to sexual differentiation. In males,
abrogate SF-1 binding in vitro (Shen et al., 1994; GiuiliSF-1 participates in sexual development by regulat-
et al., 1997). Because SF-1 is essential for the develop-
ing expression of the polypeptide hormone MuÈ llerian ment of multiple endocrine tissues, mechanisms must
inhibiting substance (MIS). Here, we show that WT1
exist to restrict expression of SF-1 target genes, such
2KTS isoforms associate and synergize with SF-1 to as MIS, to the appropriate cell types.
promote MIS expression. In contrast, WT1 missense A second gene essential for mammalian gonadal and
mutations, associated with male pseudohermaphro- kidney development is WT1, which encodes a zinc-fin-
ditism in Denys-Drash syndrome, fail to synergize with ger transcription factor (Pritchard-Jones et al., 1990;
SF-1. Additionally, the X-linked, candidate dosage- Pelletier et al., 1991a; Kreidberg et al., 1993). Mutations
sensitive sex-reversal gene, Dax-1, antagonizes syn- in WT1 are associated with childhood tumors of the
ergy between SF-1 and WT1, most likely through a kidney, thus supporting WT1 as a tumor suppressor
direct interaction with SF-1. We propose that WT1 and gene (Call et al., 1990; Gessler et al., 1990). WT1 mu-
Dax-1 functionally oppose each other in testis devel- tations are also associated with three pediatric syn-
opment by modulating SF-1±mediated transactivation. dromes: WAGR (Wilms' tumor, Aniridia, Genitourinary
abnormalities, and mental Retardation), Denys-Drash
Introduction syndrome (DDS), and Fraiser syndrome (Little and Wells,
1997). One prominent feature shared by these distinct
To date, two related genes, Sry and Sox9 have been syndromes is a high incidence of urogenital defects.
identified to direct or participate in testis determination Although defects in gonadal and reproductive tract de-
(Koopman et al., 1990; Sinclair et al., 1990; Foster et al., velopment can vary widely in these patients, most 46,XX
1994; Wagner et al., 1994; Kent al., 1996). Both of these females appear normal, while the majority of 46,XY indi-
putative transcription factors are expressed in the testis, viduals exhibit ambiguous genitalia or male pseudoher-
but not the ovary, and must coordinate differentiation maphroditism.
of Sertoli cells in the embryonic testes. Subsequently, In over sixty percent of DDS patients, de novo germ
Sertoli-cell expression of MIS regulates secondary sex- line WT1 missense mutations cluster in exon 9, which
ual development in males by triggering the regression encodes the third zinc finger (Reddy and Licht, 1996;
of the MuÈ llerian duct, the anlagen of the female repro- Little and Wells, 1997). Recreation of DDS WT1 muta-
ductive tract. Female-specific genes that direct ovarian tions in vitro demonstrates a loss of DNA binding to
development have yet to be identified, although one candidate target elements and an altered subnuclear
candidate is the X-linked gene, DAX-1, encoding an localization corresponding to the splicing apparatus
orphan nuclear receptor (Zanaria et al., 1994). DAX-1 is (Pelletier et al., 1991a; Englert et al., 1995; Larsson et
al., 1995). It is proposed that a dominant-negative mech-located on the short arm of the X chromosome within
anism accounts for the DDS phenotype due to competi-the dosage-sensitive sex-reversal (DSS) locus. Duplica-
tion between DDS mutant and wild-type WT1 proteinstion of the DSS locus (Xp21.2-p21.3) in males overrides
for homodimerization (Pelletier et al., 1991a). Under-the male program of development, resulting in XY sex
standing how the WT1 protein mediates urogenital de-reversal (Muscatelli et al., 1994; Zanaria et al., 1994).
velopment has been hampered because clear transcrip-An obligatory gene for mammalian gonadogenesis is
tional targets have yet to be identified. Although boththe autosomal Ftz-f1 gene encoding the orphan nuclear
SF-1 and Wt1 are essential for gonadogenesis, the dis-receptor SF-1 (for review, Parker and Schimmer, 1997).
similar phenotypes displayed by mice with Wt1 versusMice homozygous for a SF-1 null mutation display a
SF-1 gene disruptions imply that these two genes havelack of gonadal and adrenal development (Luo et al.,
distinct roles in development. Thus far, there has been1994; Sadovsky et al., 1995; Shinoda et al., 1995), a loss
no evidence to suggest that these two genes are posi-of pituitary gonadotropins (Ingraham et al., 1994), and
tioned in series within a genetic cascade (Parker and
Schimmer, 1997).
We have focused on the molecular mechanisms that³To whom correspondence should be addressed.
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Figure 1. SF-1 and WT1 Act Synergistically To Regulate MIS
(A) Nonradioactive in situ hybridization demonstrates colocalization of WT1 and MIS signals to the developing seminiferous tubules in E15.5
rat testes.
(B) WT1 isoforms. WT1 products result from alternative splicing at two sites; 1 or 2 indicates inclusion or exclusion of one or both sites,
respectively. Ex5: exon 5, KTS: Lys-Thr-Ser.
(C) JEG-3 cells were transiently transfected with the MIS-luciferase reporter construct (2X-MIS-RE; 0.3 mg) in the absence or presence of 0.1
mg SF-1, 0.5 mg WT1, or a combination of SF-1 and WT1 isoforms. Luciferase activity was measured in relative light units (RLU) and is reported
as fold induction above background activity produced by 2X-MIS-RE alone. The average potentiation of SF-1 activation by WT1 2KTS was
determined to be 21 6 2.3 on the 2X-MIS-RE reporter for at least nine independent experiments.
(D) Western blot analysis of extracts from transfected JEG-3 cells is shown for SF-1, WT1 isoforms (1/2, 1/1, 2/2), and the pcDNA3 control
vector (C) using anti-SF-1 (1:5000 dilution; K. Morohashi), and anti-WT1 (1:4000 dilution; C-19, Santa Cruz Biotechnology).
control male-specific gene expression of MIS given its localizes to the basal epithelium of the seminiferous
tubule, suggesting strongly that WT1 is expressed selec-pivotal position downstream of SRY in the mammalian
sex determination pathway. Becauseexpression of SF-1 tively in Sertoli cells (Larsson et al., 1995). WT1 is also
expressed in the embryonic Sertoli or pre-Sertoli cellis far wider than that of MIS, we initiated a search for a
cofactor that might act in concert with SF-1 to direct where it colocalizes with MIS transcripts in E15.5 testis
(Figure 1A). Four major isoforms of WT1 are generatedSertoli cell±specific expression of MIS. We predicted
that this cofactor may also be present in the postnatal by alternative splicing, all of which are expressed in
WT1-positive tissues. Alternative splicing of exon 5 re-granulosa cell where female expression of MIS is ob-
served. Here, we report that the WT1 gene product inter- sults ina 17amino acid insertion, and alternative splicing
of exon 9 produces an insertion of Lys-Thr-Ser (1KTS)acts with SF-1 and markedly increases expression of
MIS-reporter constructs. Our results suggest that SF-1 between the third and fourth zinc finger. The three WT1
isoforms used in this study are depicted in Figure 1B.achieves cell-specific gene expression by recruiting a
factor (WT1) unrelated to the nuclear receptor superfam- Given the Sertoli cell expression of WT1 in the embry-
onic testis, we set out to test whether WT1 would influ-ily. Because of the potential for DAX-1 to repress male-
specific genes, we also investigated the role of Dax-1 ence MIS expression by itself or in combination with the
orphan nuclear receptor, SF-1. We chose to use the humanto influence the activity of SF-1 and WT1 in our in vitro
system. We provide molecular evidence that the dosage placental cell line, JEG-3, for our studies because this
cell line is null for both SF-1 and WT1 expression (Figureof Dax-1, as well as WT1, are important for male sexual
development. Based on our findings, we present a 1D), and SF-1 will activate known target response ele-
ments in transient transfection assays (Ito et al., 1997).model whereby Dax-1 and WT1 oppose each other to
affect SF-1±mediated transactivation of male-specific A MIS-reporter construct containing two MIS-RE-1 ele-
ments (2X-MIS-RE) was activated robustly followinggenes.
cotransfection with SF-1. By contrast, WT1 was unable
toactivate the MIS-reporter construct (1- to 3-fold aboveResults
background; Figure 1C). However, cotransfection of
SF-1 and the WT1 2KTS isoforms in JEG-3 cells resultedSynergistic Activity of Specific WT1
Isoforms with SF-1 in synergistic MIS-reporter expression to levels reaching
4000-fold above background (Figure 1C). Surprisingly,In the adult gonad, WT1 expression is restricted to both
Sertoli and granulosa cells (Pelletier et al., 1991b) and the 1KTS isoform failed to synergize with SF-1. The lack
SF-1, WT1, and Dax-1 in Testis Differentiation
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Figure 2. Direct Interaction of SF-1 and WT1
(A) The yeast two-hybrid assay was used to
infer a protein±protein interaction between
SF-1 and WT1 in strain EGY48. Fusion pro-
teins were generated between the LexA-DNA
binding domain and SF-1 (pLexA2), and the
B42 activation domain fused with WT1 or
SF-1 (pB42AD2). b-galactosidase activity was
measured for combinations of experimental
or control plasmids (2), as indicated; the
standard error of the mean is shown by the
error bars. The number of independent trans-
formants measured is indicated in paren-
theses.
(B) Modified mammalian two-hybrid assay.
JEG-3 cells were cotransfected with the
2xLexA-luciferase reporter and either the
LexA-DBD or the LexA-SF-1 fusion protein
and pcDNA3.WT1 (2/2 or 1/1).
(C) HA epitope±tagged SF-1 proteins (SF-1,
SF-1DDBD) were visualized from COS whole-
cell extracts by Western analysis (anti-HA
IgG, 1:1000 dilution) after transfection of SF-1
expression plasmids. Signals from 6% of the
whole-cell extract are shown. Associated
proteins bound to GST or GST-WT1 2/2 af-
finity matrix are shown; SF-1 proteins are only
observed when incubated with GST-WT1 as indicated. Cross reactivity of the anti-HA antibody with BSA is observed in all samples.
(D) Radiolabeled in vitro translated WT1 1/2 protein was incubated with GST alone or a GST-SF-1 fusion protein, as described in Experimental
Procedures. Phosphorimager analysis of the data revealed the percent of WT1 1/2 bound to the GST or GST-SF-1 fusion protein, respectively.
Ten percent of the IVT product added to each reaction is shown (10% Input).
of activity of the WT1 1KTS isoform was not due to Synergistic Activation by WT1 is Specific
to the Conserved 25 bpdifferences in the protein expression levels as judged
MIS-RE1 Elementby Western blot analysis (Figure 1D). Thus, our func-
To determine whether a DNA component was requiredtional data show that specific WT1 2KTS isoforms syn-
for the WT1/SF-1 synergy, we tested whether WT1ergize with SF-1 to activate MIS-reporter genes in vitro.
would bind to the MIS-RE-1 site used in transfection
studies. This 25 bp element contains the core SF-1±
binding site and additional upstream sequences thatDirect Interaction between SF-1 and WT1
are highly conserved across several species. AlthoughTo determine whether direct interaction between SF-1
this element is GC rich, it does not resemble any of theand WT1 accounted for the functional synergism ob-
consensus binding sites defined for recombinant WT1served, we looked for evidence of physical association
protein (Reddy and Licht, 1996). While SF-1 was foundbetween these two proteins. Indeed, when SF-1 and
to bind with high affinity to the MIS-RE-1, a WT1/DNAWT1 2/2 were coexpressed in a yeast two-hybrid LexA-
complex was not observed on this element, nor was theB42 system, significant b-galactosidase activity was ob-
SF-1-DNA complex affected by WT1 protein (Figure 3A).served inferring a physical interaction (Figure 2A). By
Furthermore, an obvious ternary complex was not ob-comparison, interaction was reduced if SF-1 was ex-
served. On the other hand, IVT WT1 proteins were foundpressed with the WT1 1/1 isoform. Levels of WT1 fusion
capable of binding a known WT1 consensus site, the
proteins were similar for all constructs as judged by
WTE. In this case, two visible but weak DNA±protein
Western blot analysis (data not shown). Our findings in
complexes were observed for all 2KTS isoforms, includ-
the yeast two-hybrid system were confirmed using two ing a mutant form of the WT1 protein that was truncated
other independent systems. First, ina modified mamma- at the amino terminus (DN; Figure 3A).
lian two-hybrid experiment, we observed that WT1 2/2 To determine whether WT1 would increase the activa-
could augment SF-1±mediated transactivation, whereas tion of another SF-1 target gene, we tested the effects
the WT1 1/1 isoform was less active (Figure 2B). Sec- of WT1 on wild-type and mutant MIS-RE1 site(s) and
ond, SF-1 proteins expressed in COS cells were selec- the steroidogenic enzyme P450-21-hydroxylase (21-OH)
tively bound to a GST-WT1 affinity matrix (Figure 2C). element; all elements were fused to the same minimal
Similar results were obtained with in vitro translated promoter. SF-1 is known to bind as a monomer and with
(IVT) WT1 and a GST-SF-1 fusion protein (Figure 2D). high affinity. Only the core hexamer half-ERE consensus
We note that removal of the SF-1 DNA±binding domain site of ªAGGTCAº is shared by the core SF-1±binding site
(DBD) diminishes binding of GST-WT1, suggesting that of the MIS and 21-OH promoters, (CCAAGGTCA and
this region may contain crucial residues for a high affinity CAAAGGTCA, respectively). In contrast to either the
MIS-RE-1 or MIS-M1 reporter, altering the sequenceSF-1/WT1 association.
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Figure 4. Denys-Drash WT1 Mutants Fail To Synergize with SF-1
(A) JEG-3 cells were transiently transfected with the 2X-MIS-RE
reporter, SF-1, and WT1 2KTS isoforms, including point mutantsFigure 3. WT1/SF-1 Synergy Requires a DNA Component
of WT1 frequently occurring in Denys-Drash patients (C330Y: first
(A) Gel mobility shift assays were performed with radiolabeled MIS- zinc finger; R394W: third zinc finger; D396G: third zinc finger) and
RE1 or a WT1 response element (WTE; core WT1 site, GCG deletions of the N (DN: deletion aa 8-180) or C (DZF4: L398stop)
TGGGAGT; Nakagama et al. 1995) and incubated with IVT proteins. terminus of WT1. Luciferase activity is reported as fold induction
The SF-1±DNA complex, control reactions with probe alone (Pr), above background reporter activity alone. Expression of mutant
and unreacted reticulocyte lysate (RL) are shown. The amounts of proteins was comparable with wild-type WT1 (data not shown).
IVT protein used were 1.5 ml of SF-1 and 3 ml of all other proteins, (B) Interactions between SF-1 and WT1 mutants tested in a yeast
except as indicated (6 ml). Two major WT1 protein±DNA complexes two-hybrid assay. b-galactosidase activity is shown for combina-
are shown (I and II) for full-length and truncated (DN) 2KTS isoforms. tions of SF-1 and mutant WT1 fusion proteins (pB42AD2) consisting
The WT1/DNA complexes were supershifted using an antibody to of an amino terminal truncation (DN), deletion of the fourth zinc
WT1 (DN 1 aWT). A nonspecific protein±DNA interaction contributed finger (DZF4: L398stop), or a missense mutation in the third zinc
by protein in the reticulocyte lysate is indicated (NS). finger (D396G). The number of independent transformants measured
(B) JEG-3 cells were transiently transfected with luciferase reporter is indicated in parentheses.
constructs containing two wild-type (2X-MIS-RE) or mutant (2X-
MIS-M1, M2) MIS-RE-1 sites, or five P450 21-hydroxylase SF-1 re-
sponse elements (5X-21OH) with 0.3 mg. Increasing amounts of WT1
cases, the mutant WT1 proteins failed to achieve the1/2 (black bars), WT1 1/1 (gray bars), or pcDNA3 plasmid (0.1±0.5
mg) were cotransfected with a constant level of pCMV±SF-1 (0.1 levels of MIS activation observed with the wild-type
mg). The relative luciferase activity is shown as the percent change 2KTS isoform (Figure 4A). Truncation of the N terminus
from SF-1 cotransfected with pcDNA3 (open bar). Sequence com- (D8-180) as well as the fourth zinc finger (DZF4 2/2) also
parison of the wild-type MIS-RE1, mutant sites, and the mouse 21-
abolished activity; the D8-180 deletion includes most ofOH is shown with the core SF-1±binding site indicated.
the putative proline-glutamine transactivation and di-
merization domains but does not eliminate nuclear local-
ization of WT1 (Larsson et al., 1995). It should be notedupstream of this core SF-1±binding site abrogates the
functional association between SF-1 and WT1 1/2, de- that the three DDS mutants retained some ability to
boost SF-1 activity (2- to 4-fold increase). As proposedspite a 10- to 20-fold activation of these reporters by
SF-1 (21-OH and MIS-M2, Figure 3B). Thus, a DNA com- for WT1 homodimerization, the proline-glutamine±rich
region of WT1 also appears to be critical in mediatingponent provided by the MIS-RE1 element is required for
WT1 to potentiate SF-1 activation. a SF-1/WT1 interaction, whereas the WT1 zinc-finger
region is less critical (Figure 4B).
DDS WT1 Mutants Fail To Synergize with SF-1
Although the profile of patients diagnosed with DDS is Dax-1 Interacts with SF-1 and Represses
WT1/SF-1 Synergismcomplex and varied, most 46,XY DDS patients exhibit
genital abnormalities, some with persistence of the MuÈ l- Like SF-1, the nuclear receptor Dax-1 is expressed in
interstitial and Sertoli cells of the embryonic testis. Thelerian duct structures. Therefore, three of these muta-
tions were recreated in the WT1 2KTS background and potential interaction between SF-1, Dax-1, and WT1 in
the activation of MIS is especially relevant given thetested for their ability to potentiate SF-1 activity. In all
SF-1, WT1, and Dax-1 in Testis Differentiation
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Figure 5. Dax-1 Interacts with SF-1 and Ab-
rogates SF-1/WT1 Synergy
(A) JEG-3 cells were transiently transfected
with the 2X-MIS-RE reporter, SF-1 (0.1 mg),
WT1 1/2 (0.3 mg), and increasing concentra-
tions of full-length and mutant Dax-1 proteins
(corresponding to 0.1±23 of SF-1) or WT1
isoforms (corresponding to 0.5±2x of the
WT1 1/2). A schematic of Dax-1 depicts the
boundaries of the cysteine repeats (arrows)
and two putative silencing domains, A and B,
as defined by Ito et al. (1997) and Lalli et
al. (1997), with numbering of amino acids
shown for mouse Dax-1. Luciferase activity
is reported as expression relative to levels
achieved by SF-1/WT1 synergy. Nuclear lo-
calization of FLAG epitope±tagged full-length
Dax-1 and the most severely truncated Dax-1
mutant protein (1-99) was detected in trans-
fected JEG-3 cells using an anti-FLAG anti-
body (KODAK; 1:3000 dilution).
(B) Dax-1 interacts with SF-1 in a yeast two-
hybrid system. b-galactosidase activity is
shownin yeast cotransformed with Dax-1 and
SF-1 orWT1. Five independent transformants
were measured for each combination.
(C) Radiolabeled IVT SF-1 or SF-1 lacking the
putative ligand binding domain (SF-1DLBD)
protein was incubated with GST alone, GST-
WT1 2/2, or GST-Dax-1 fusion proteins. A
Coomassie-stained gel shows the relative
amount of each fusion protein used in this
assay: right panel.
proposed role of DAX-1 in repressing male-specific data, although with a lower affinity than observed for a
WT1/SF-1 interaction (Figure 5C; Ito et al. 1997). Inter-genes (Zanaria et al., 1994). We explored the role of
Dax-1 in modulating the activation of MIS by SF-1 and estingly, removal of the SF-1 ligand±binding domain ab-
rogated its interaction with GST-Dax-1, but not withWT1. Marked reduction of MIS activation was observed
if Dax-1 was cotransfected simultaneously with SF-1 GST-WT1, suggesting that the major sites conferring
interaction with Dax-1 and WT1 may be mediated byand WT1 (Figure 5A). Truncating one of the putative
inhibitory domains of Dax-1 failed to relieve this repres- distinct regions on SF-1. Previous studies by others
using human DAX-1 and mouse SF-1 have failed tosion (Dax 1-276 and 1-427), although at low concentra-
tions the magnitude of inhibition with Dax 1-427 was detect a direct interaction in vivo, possibly due to the
high degree of protein divergence between human andslightly less when compared to wild-type Dax-1 (Figure
5A). In contrast, removing both inhibitory domains (Dax mouse Dax-1 (65% identity). The use of mouse Dax-1
may underlie our ability to detect such an interaction.1-249) or the entire ligand-binding domain (LBD) and
portions of the cysteine repeats (Dax 1-99) relieved re- In summary, our data suggest that Dax-1 does not bind
the MIS-RE1 element, butcan heterodimerize with SF-1,pression without altering nuclear localization (Figure
5A). Cotransfection of Dax-1 and SF-1 in the absence and represses the functional interaction between WT1
and SF-1.of WT1 did not yield a similar inhibitory effect (data
not shown). Because DDS WT1 mutations have been
proposed to act in a dominant-negative fashion, we also
tested the ability of two DDS mutants to disrupt the Expression of WT1 Isoforms and Dax-1
in Gonadal DevelopmentWT1 synergistic function with SF-1. In contrast toDax-1,
increasing levels of DDS mutants at ratios of 1:1 or The dramatic functional difference between the 1KTS
and 2KTS WT1 isoforms in mediating the SF-1/WT1greater than wild type failed to reduce the synergistic
activity of SF-1 and WT1 (Figure 5A). synergy and the repression of this synergy by Dax-1
led us to examine the relative transcript levels of theseGiven this marked effect of Dax-1 on the SF-1/WT1
synergy, we investigated whether Dax-1 could interact nuclear factors in sexual development. Whole-mount in
situ hybridization analysis revealed that in contrast towith SF-1 and/or WT1. We noted previously that Dax-1
was unable to bind DNA and failed to form a visible the sexually dimorphic expression pattern of SF-1, WT1
is equivalent in male and female E15.5 gonads (FigureDax-1/SF-1 protein±protein complex on the MIS-RE-1
element (Figure 3A). However, in the yeast two-hybrid 6A). Furthermore, RNAse protection analysis showed
that at all developmental stages examined the relativeassay, a prominent association between SF-1 and Dax-1,
but not WT1 and Dax, was detected (Figure 5B). Further- levels of WT1 (1KTS or 2KTS) in the testis and ovary
were not different. Both WT1 isoforms are present inmore, a Dax-1/SF-1 interaction was noted in a GST pull-
down experiment consistent with previously published the embryonic kidney, as expected, and nearly absent
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of MIS (1991b). Indeed, WT1 mutations are often asso-
ciated with persistent MuÈ llerian duct structures, con-
sistent with MIS disregulation (Little and Wells, 1997).
However, as shown here, WT1 is unable to activate MIS-
reporter constructs by itself. Our earlier studies proved
SF-1 to be an essential but not sole regulator of MIS
(Shen et al., 1994; Giuili et al., 1997). Based on these
data we conclude that neither SF-1 nor WT1 is sufficient
to direct cell-specific MIS expression. Here, we show
that SF-1 and WT1 work in concert to affect expression
of a male-specific gene (MIS) positioned downstream
of Sry. Furthermore, Dax-1 serves to antagonize the
functional interaction between SF-1 and WT1, sug-
gesting that the interplay between SF-1, WT1, and Dax-1
may account for the activation or repression of male-
specific genes.
A Tissue-Specific Cofactor for SF-1
Coactivators and corepressors are now knownto modu-
late ligand-activated nuclear receptors as well as other
transcription factors (Perlmann and Evans, 1997). The
ubiquitous nature of these cofactors makes it unlikely
that they contribute to the tissue-specific expression of
Figure 6. Levels of SF-1, WT1, and Dax-1 in the Developing Gonad
target genes activated by nuclear receptors. WT1 may
(A) Whole-mount nonradioactive in situ hybridization of WT1 and
therefore serve as one of the first examples of a tissue-SF-1 in the developing gonad. Genital ridges were harvested from
specific cofactor of a nuclear receptor. It is of inter-embryonic rats at E15.5, fixed, and hybridized with probe as indi-
est that another WT1-related zinc-finger protein, Egr-1cated. Female organs appear on the left and male organs on the
right in each panel. (Zif268, NGFI-A, Krox-24), functionally synergizes with
(B) Levels of WT1 (2KTS and 1KTS) and Dax-1 transcripts from total SF-1 to regulate the b subunit of luteinizing hormone,
RNA isolated from the embryonic gonads (minus the mesonephros) LHb (Lee et al., 1996). In this scenario, distinct DNA-
were examined by RNase protection analysis at three stages of
binding elements for SF-1 and Egr-1 are present in theembryonic development, E13.5, E15.5, and E18.5. Actin serves as
LHb promoter, suggesting that a direct protein associa-an internal control for amount of total RNA. Signals shown for WT1
tion between SF-1 and Egr-1, as postulated here forand Dax-1 represent equivalent exposure times at all stages. A
longer exposure (103) is also shown for Dax-1 at E13.5 (asterisk). SF-1 and WT1, may not be required for the observed
synergism. Several studies infer that multiple mecha-
nisms can modulate SF-1's activity depending on the
cellular and developmental context. SF-1 is influencedin the adrenal gland (Figure 6B). Consistent with previ-
by cofactors, such as WT1 and Dax-1 (this study andous in situ analyses at early stages of sexual differentia-
Ito et al. 1997), by ligands (Lala et al., 1997), and bytion (Ikeda et al., 1996), we find that Dax-1 levels are
posttranslational modifications (Zhang and Mellon, 1996).equivalent in the ovary and testes and are noted to be
Our data suggest that the subset of monomer-bindingmuch lower than WT1 (E13.5 and E15.5, Figure 6B).
nuclear receptors like SF-1 can recruit non±DNA-bind-Dax-1 isalso present transiently in early stages of kidney
ing partners, such as WT1 and Dax-1, to affect genedevelopment (E15.5). Later in gonadal development,
expression. These partners could fulfill a role analogousDax-1 is high in the testis and low in the ovary (E18.5,
to the homo- or heterodimeric DNA-binding partnersFigure 6B). Because Dax-1 is expressed in interstitial
known to exist for the majority of other nuclear receptorsLeydig cells (Ikeda et al., 1996) and in Sertoli cells (Tamai
(Mangelsdorf et al., 1995).et al. 1996; J. N. F. and H. A. I., unpublished data), this
increase in testicular Dax-1 expression may arise from
Leydig cell expression. Curiously, our findings differ DDS Mutants: Dosage Sensitivity
from another earlier report where Dax-1 was shown to or Dominant-Negative Proteins?
be down-regulated at later stages of testicular develop- Intersex/genitourinary defects in the Denys-Drash syn-
ment (Swain et al., 1996). drome are frequently associated with germline heterozy-
gous missense mutations of the WT1 gene. Phenotypes
associated with DDS, and particularly renal nephropa-Discussion
thies, are thought to arise via a dominant-negative
mechanism rather than simple haploinsufficiency (Pel-Genetic studies have identified SRY (Sry) and implicated
DAX-1 as factors that promote or oppose, respectively, letier et al., 1991a). DDS mutant proteins are proposed
to associate with wild-type WT1, thereby either reducingthe development of the bipotential gonad into the testis.
Two other nuclear proteins, SF-1 and WT1, are also DNA binding of WT1 2KTS to target sites or subverting
the subnuclear localization of the WT1 2KTS isoformsessential for establishing the bipotential gonad in both
sexes. Previously, Pelletier and colleagues hypothe- to the splicing apparatus, where WT1 1KTS isoforms
are normally distributed (Englert et al., 1995; Larsson etsized that WT1 may modulate male-specific expression
SF-1, WT1, and Dax-1 in Testis Differentiation
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al., 1995). Both mechanisms effectively lower transcrip- testicular function. Paradoxically, in vitro studies show
that DAX-1 inhibits SF-1±mediated transactivation bytionally active WT1 2KTS. We find that DDS WT1 mu-
tants fail to interact functionally with SF-1 but are able binding DNA directly or by heterodimerization with SF-1
(Ito et al., 1997; Zazopoulos et al., 1997). In our in vitroto associate in a two-hybrid assay (Figure 4C). Unex-
pectedly, overexpression of these missense WT1 mu- system, Dax-1 inhibits the SF-1/WT1 synergy; however,
Dax-1 inhibition of SF-1±mediated transactivation alonetants did not reduce wild-type WT1 activity as predicted
for a dominant-negative protein. These data rekindle the is not robust. Therefore, both the cellular and the pro-
moter context are likely to affect the functional conse-debate as to how WT1 missense and nonsense mutants
lead to genital defects. Self-association of WT1 is rela- quence of SF-1 and Dax-1 interactions, just as these
factors influence the SF-1/WT1 synergy. The notion thattively weak when compared with SF-1/WT1 association
(M. W. N. and H. A. I., unpublished data; Moffett et al., Dax-1 may function solely as a repressor or ªanti-testis
factorº is difficult to reconcile with the increased Dax-11995; Reddy et al., 1995). Moreover, severe urogenital
disorders are observed in some Wilms' tumor patients expression observed at later stages of testis develop-
ment. It is plausible that in late embryonic or adult testes,predicted to have too little of the N-terminal portion of
WT1 to associate with wild-type WT1 (Little and Wells, an available ligand converts Dax-1 from a repressor to
an activator as proposed (Lalli et al., 1997).1997). Thus, in considering our dataand others, we favor
a model in which mutant DDS proteins are localized In many respects, WT1 and Dax-1 interact with SF-1
in similar ways, albeit with dramatically different out-away from the transcriptional machinery, effectively re-
ducing the dosage of wildtype WT1 2KTS protein (Lars- comes. WT1 and Dax-1 are unable to bind specifically
to a SF-1 response element, neither interferes with SF-1son et al., 1995). Additionally, these mislocalized DDS
mutant proteins could act as antimorphs to affect the binding, and the strength of their interactions with SF-1
is relatively weak based on the inability to detect promi-normal functions of the 1KTS isoform. Differential local-
ization of the 1KTS and 2KTS isoforms may also ac- nent protein±protein complexes on DNA or to coimmu-
noprecipitate a SF-1/WT1 complex. The nature of SF-1/count for the intersex disorders observed in Frasier syn-
drome. This syndrome is associated with a WT1 mutant WT1 and SF-1/Dax-1 interactions promises to be com-
plex given that WT1 or Dax-1 mutants physically associ-predicted to alter the splice isoform ratio, resulting in
lower WT1 1KTS levels (Barbaux et al., 1997). In our ate with SF-1 but are functionally inactive (this study;
Ito et al., 1997). WT1 and Dax-1 could simply competeassay the WT1 1KTS is inactive, so how might lowering
this isoform lead to loss of male-specific gene expres- for each other in their interactions with SF-1; however,
data shown here suggest that these molecules interactsion? Decreasing the 1KTS isoform may shift the bal-
ance of WT1 2KTS associated with the transcriptional with different regions of SF-1. It is possible that all three
molecules form a complex tethered to DNA by SF-1 andmachinery; alternatively, WT1 1KTS may participate in
the processing of RNAs that encode additional factors that WT1 and Dax-1 functionally oppose each other by
altering the balance of ubiquitous coactivators or core-required for male urogenital development.
Examination of several DDS mutants revealed that the pressors associated with SF-1. Further studies are
needed to delineate the structural basis for the func-majority of 46,XY patients exhibit gonadal abnormalities,
while most 46,XX patients exhibit normal ovarian devel- tional interaction of SF-1, WT1, and Dax-1.
The relative dosage of SF-1, WT1, and DAX-1 mayopment (Little and Wells, 1997). One implication sug-
gested by the phenotypic differences among male and now be considered in the context of mammalian sexual
development. While SF-1 is high in males and promotesfemale DDS patients would be that monoallelic expres-
sion of wild-type WT1 is insufficient for testicular ma- male development by regulating MISand genes involved
in testosterone production, DAX-1 has been suggestedturation but adequate for ovarian development. Thus,
male-specific genes may be extremely sensitive to the to antagonize male development because it is associ-
ated with the duplicated X-linked dosage-sensitive sex-dosage of WT1. Our data raise the possibility that at
least for some genes, such as MIS, haploinsufficiency, reversal locus in 46,XY females. We propose that over-
expression or a double dose of the DAX-1 gene in theseand not gain-of-function mutations, account for the phe-
notype observed in male DDS and WAGR patients. XY females may impair testis development by interfering
with SF-1/WT1 synergy (Figure 7). Indeed, during revi-
sion of this manuscipt, gain-of-function studies revealed
Interaction between SF-1, WT1, and Dax-1 that high doses of Dax-1 can counteract Sry in a weak-
and Mammalian Sexual Differentiation ened Sry allelic background or in XX sex-reversed male
The gene products of Ftz-f1 (SF-1), WT1, and DAX-1 mice (Swain et al., 1998). However, these studies also
are all implicated in mammalian sexual development. serve to illustrate that sensitivity to gene dosage during
Colocalization of SF-1 and WT1 is restricted to Sertoli sexual development differs in rodents and humans. Sim-
and granulosa cells, consistent with their roles in MIS ilarly, this difference in sensitivity is noted with the gene
gene regulation. SF-1 and Dax-1 colocalize in multiple dosage of WT1, where monoallelic expression is known
endocrine tissues, suggesting that these two nuclear to affect genital development in humans but not in mice
proteins may be linked in function (Ikeda et al., 1996). (Kreidberg et al., 1993). In the Denys-Drash syndrome,
Human DAX-1 loss-of-function mutants exhibit adreno- a 50% reduction of transcriptionally active WT1 2KTS
hypoplasia congenita (AHC), with some disruption of is predicted toshift thebalance of WT1 relative toDAX-1,
the hypothalamic-pituitary-gonadal axis (Zanaria et al., thereby favoring the DAX-1/SF-1 interaction (Figure 7).
1994), implying that like SF-1, DAX-1 is critical for adre- As a consequence, male-specific genes are suppressed,
resulting in impaired male sexual development. It followsnal development and, at least at puberty, for normal
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density of 1±2 3 105 per 22 mm plate (12-well) in Dulbecco's modified
Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS)
and antibiotics. One day later, cells were cotransfected with expres-
sion and reporter plasmids using a standard calcium phosphate
precipitation method (Mammalian Transfection Kit; Specialty Media)
and harvested 36 hr later. Luciferase activity was measured using
the Enhanced Luciferase Assay (Analytical Luminescence Labora-
tory). Experiments were performed at least three times in triplicate
with different preparations of plasmid. b-galactosidase activity was
measured as an internal control for transfection. COS cells were
plated at a density of 5 3 106 per 100 mm plate in DMEM/10% FBS
and antibiotics 24 hr prior to transfection. COS cells were trans-
fected using an adenovirus-mediated procedure essentially as de-
scribed in Allgood et al. (1997).
Gel Shift Binding Studies and GST Pull-Down Assays
Gel mobility shift assays were performed as previously described,
except that the buffer for binding to the WTE site was modified
(Nakagama et al., 1995). Noncompetitor single-stranded DNA was
lowered to detect optimal binding on this site. Binding reactions
were carried out (in 20 mM HEPES [pH 7.9], 60 mM KCl, 4 mM Tris-
Cl [pH 8.0], 0.6 mM EDTA, 0.6 mM EGTA, 12% glycerol, 5 mM DTT,
50 mg/ml BSA, 5 mg/ml salmon sperm DNA, 5 mg/ml poly dI-dC,
0.25% milk, 10 mM ZnSO4), using in vitro translated proteins and 32P
end-labeled annealed MIS-RE-1 oligonucleotides. Prior to binding
assays, individual in vitro translated proteins were radiolabeled and
checked by 10% SDS-PAGE analysis. Sequences for oligonucleo-
tides were as follows: MIS-RE-1, 59-GCCAGGCACTG-TCCCCCAAG
GTCACCTT-39 (Shen et al., 1994); WTE, 59-CGGATCCGCCAGCGT-
GGGAGTACCTTAGATCTG-39 (Nakagama et al., 1995).
GST pull-down assays were conducted using 20 ml of a 50%
GST-protein beads slurry suspended in binding buffer; 20 mM
HEPES (pH 7.9), 100±500 mM NaCl, 1 mM EDTA, 4 mM MgCl2, 1
mM DTT, 10% glycerol, 0.01% NP40, 1 mg/ml BSA, and protease
Figure 7. SF-1, WT1, and DAX-1 in Male Sexual Development inhibitor cocktail mixed with 4 ml of [35S]cysteine/methionine radiola-
beled IVT reactions in a 150 ml reaction volume for 60 min at 378C.A model depicting our results and three genetic conditions in human
After washing three times in the same buffer, bound proteins were46,XY individuals is shown. Because SF-1 and WT1 are autosomal
visualized after separation on a 10% SDS-PAGE by autoradiogra-genes, whereas DAX-1 is X-linked, the relative gene dosage of WT1
phy. The GST fusion proteins were made using mouse SF-1 corre-2KTS to DAX-1 would normally be 2:1. Male-specific genes, such
sponding to amino acids 265-462 and full-length mouse WT1 2/2as MIS, are on because the synergistic interactions between SF-1
and Dax-1 (Guo et al., 1996) inserted into a pGEX vector (Pharmacia).and WT1 are favored. In XY dosage±sensitive sex-reversal, male-
COS whole-cell extracts were made by lysis in 50 mM HEPES, 250specific genes are off because a double dose of DAX-1 competes
mM NaCl, 0.5 mM EDTA, 0.1% NP40, and protease inhibitor cocktail.functionally with WT1 for interaction with SF-1; the ratio of WT1:
Binding reactions were performed in binding buffer, as describedDAX-1 is 2:2 in this scenario. In DDS, XY individuals with heterozy-
above, in a total volume of 625 ml for 30 min at 378C. Proteins weregous missense WT1 mutations reduce the levels of wild-type 2KTS
visualized by Western analysis and 9% SDS-PAGE.isoform by half. In these individuals the ratio of WT1:DAX-1 is 1:1.
In all three conditions, the gene dosage of SF-1 remains at 2. The
LexA Yeast Two-Hybrid AssaysWT1 1KTS isoform is shown in association with the splicing appara-
Plasmids pEG202, pJG4-5, pSH18-34, and yeast strain EGY48 weretus, small nuclear ribonucleoproteins (snRNPs).
obtained from CLONTECH. Plasmid pEG202.SF-1 and pJG4-5.SF-1
were constructed using full-length mouse SF-1 (nt. 1-1389) inserted
into BamH1/Xho1 sites. To construct pJG4-5.WT1 2/2, pJG4-that Sry and/or Sox9 may function to increase the rela-
5.WT1 1/1, pEG202.Dax-1, and pJG4-5.Dax-1 mouse cDNAs en-tive levels of SF-1 in the bipotential gonad to initiate
coding the WT1 isoforms or Dax-1, respectively, were used as tem-male sexual development. Future genetic manipulations
plate and amplified by PCR, which introduced an EcoRI site at the
of Ftz-f1 (SF-1), Wt1, and Dax-1 in vivo should help N terminus and an XhoI site at the C terminus. The WT1 D8-180
to delineate how dosage sensitivity of these and other mutant was created by an internal PpuMI digestion. To examine
factors operate in mammalian sex determination. b-galactosidase activities, strain EGY48 was cotransformed with
the lexAop-lacZ reporter plasmid pSH18-34 and either pEG202 or
a pEG202-derived plasmid and pJG4-5 or a pJG4-5±derived plas-Experimental Procedures
mid. At least five independent transformants of each combination
were streaked out on Galactose/Raffinose-HIS-TRP-URA/X-GalPlasmid Constructions and Transfection Assays
plates for whole plate assays. Additionally, b-galactosidase activitycDNAs encoding the relevant isoforms of mouse WT1 were placed
was measured from several independent transformants in a liquidin the eucaryotic expression vector, pCDNA3, using unique EcoRI-
culture assay using ONPG as substrate. Activity was normalized toXhoI sites from the pWT1 1/2, 2/2, and 1/1 isoforms (generous
growth (OD 600) and assay time according to the formula providedgift from J. Pelletier and D. Housman). All DDS WT1 mutants were
by CLONTECH.generated by standard site-directed mutagenesis. Deletion of the
N terminus was accomplished by Ppum1 digestion followed by reli-
gation. LexA-SF-1 fusion proteins were obtained by fusing the entire In Situ Hybridization and RNase Protection Assays
Whole-mount in situ protocols were performed on paraformalde-coding region of mouse SF-1 minus the DBD (aa 11-124) to the
LexA-DBD at a unique BstEII site of pCMV.LexA (Ingraham et al., hyde (PFA)-fixed rat genital ridges treated with proteinase K (10
mg/ml; 30±45 min at room temperature) and refixed with 4% PFA.1990).
For cell transfection experiments, JEG-3 cells were plated at a Tissues were incubated with digoxigenin (DIG)-labeled RNA probes,
SF-1, WT1, and Dax-1 in Testis Differentiation
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generated from full-length mouse WT1 cDNA or rat SF-1 cDNA (nt. reversal caused by mutations in an SRY-related gene. Nature 372,
525±530.47-879), in hybridization buffer (1.33 SSC (pH 5), 50% formamide,
0.2% Tween-20, and 0.5% CHAPS) overnight at 658C. After exten- Gessler, M., Poustka, A., Cavenee, W., Neve, R.L., Orkin, S.H., and
sive washing and blocking (60 min in Boehringer Mannheim blocking Bruns, G.A. (1990). Homozygous deletion in Wilms tumours of a
reagent), tissues were incubated overnight at 48C with anti-DIG anti- zinc-finger gene identified by chromosome jumping. Nature 343,
body (1:2000; Boehringer Mannheim). After washing, color develop- 774±778.
ment was performed using BM Purple AP Substrate for 30±60 min Giuili, G., Shen, W.H., and Ingraham, H.A. (1997). The nuclear recep-
at RT. tor SF-1 mediates sexually dimorphic expression of Mullerian inhib-
In situ hybridization on cryosections (10 mm) of PFA-fixed rat iting substance, in vivo. Development 124, 1799±1807.
genital ridges were performed according to the Nonradioactive In
Guo, W., Lovell, R.S., Zhang, Y.H., Huang, B.L., Burris, T.P., Craigen,Situ Hybridization Application Manual (Boehringer Mannheim) with
W.J., and McCabe, E.R. (1996). Ahch, the mouse homologue ofthe following modifications. Sections were hybridized (50% for-
DAX1: cloning, characterization and synteny with Gyk, the glycerolmamide, 20 mM Tris-Cl [pH 8.0], 5 mM EDTA, 300 mM NaCl, 13
kinase locus. Gene 178, 31±34.
Denhardt's, 10 mM NaH2PO4 [pH 8.0], 10% dextran sulfate, 0.5
Hatano, O., Takayama, K., Imai, T., Waterman, M.R., Takakusu, A.,mg/ml tRNA) with DIG-labeled probe overnight at 608C. After high
Omura, T., and Morohashi, K. (1994). Sex-dependent expression ofstringency washes, signals were detected using anti-DIG (1:1000;
a transcription factor, Ad4BP, regulating steroidogenic P-450 genes60 min at RT). Color development used the NBT-BCIP substrate
in the gonads during prenatal and postnatal rat development. Devel-(Boehringer Mannheim). The WT1 probe is the same as described
opment 120, 2787±2797.above; the rat MIS probe is as described (Shen et al., 1994).
Ikeda, Y., Luo, X., Abbud, R., Nilson, J.H., and Parker, K.L. (1995).RNase protection assays were performed using the Ribonuclease
The nuclear receptor steroidogenic factor 1 is essential for the for-Protection Assay kit (Ambion). RT-PCR was used to isolate cDNA
mation of the ventromedial hypothalamic nucleus. Mol. Endocrinol.fragments of rat WT1 (372 bp), encompassing the 1KTS region, and
9, 478±486.rat Dax-1 (694 bp; nts 248±942). Both were subcloned into pCRII
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